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1. Introduction 
Detection and characterization of autoantibodies reacting with self-antigens is generally 
used in laboratory diagnostics. However, the presence of different autoantibodies in the 
blood serum doesn’t mean automatically a pathologic condition. Autoantibodies are present 
both in different diseases as autoimmune diseases, chronic inflammation or infections, and 
in healthy individuals without any symptoms. The present paper discusses the detailed 
analysis of recognition pattern and fine epitope specificity of these autoantibodies to better 
understand of their occurrence and evolution, and their role in physiologic and pathologic 
conditions. 
1.1 Evolution of the immunological recognition 
Microorganisms present in the environment continuously come into contact with the human 
body through external or internal surfaces. Most microorganisms are neutral or useful, but 
others – so called pathogens - are dangerous for the other living beings including human 
individuals. During evolution all multicellular organisms have developed defence 
mechanisms capable of eliminating these invading pathogens without causing damage to 
self structures. All vertebrates and invertebrates manage self and non-self discrimination. 
Consequently, discriminating self from non-self is of key importance for directing immune 
functions effectively, operating on the basis of distinct recognition systems. Any attempt to 
answer questions concerning recognition must consider the universality of receptor-
mediated responses. These may be designated to two forms: pattern recognition receptors 
and rearranging clonally distributed antigen-specific receptors that distinguish between self 
and non-self. 
1.1.1 Pattern recognition as a basic immune function  
Innate immunity serves as first line of defence against pathogens. Its early evolutionary 
appearance is indicated by its presence in all multicellular organisms including plants, 
invertebrates and vertebrates. Since invertebrate species rely on innate defence mechanisms 
only, survival of the species in the presence of environmental pathogens is achieved at the 
level of the population, which means that individual members, up until a fraction of total 
population, are dispensable (Kvell et al., 2007). Innate immunity uses receptors that are 
ancient in their evolutionary origin. These non-clonally distributed receptors have to be able 
to recognize a wide variety of molecular structures associated with pathogens without 
www.intechopen.com
 
Insights and Perspectives in Rheumatology 
 
4 
damaging self-structures. The problem lies in the discrepancy between the vast 
heterogeneity of pathogens and the limited number of possible recognizing receptors in the 
genome. This implies that the relatively few available specific receptors must recognize 
structures shared by large groups of pathogens, and that the recognized structures have to 
be pathogen-specific molecular patterns rather than particular molecules specific for 
pathogens. These pathogen associated molecular patterns (PAMPs) are conserved products of 
microbial metabolism, they are highly glycosylated, and are essential for microbial survival. 
The receptors recognizing these PAMPs are termed pattern recognition receptors (PRRs). We 
distinguish three functional classes of PRRs: endocytic receptors such as cellular C-type lectins, 
scavenger receptors and Mac-1 (CD11b:Cd18), which facilitate opsonisation and phagocytosis. 
This type of recognition is predominantly based on sugar-sugar interactions. The second set of 
PRRs are secreted proteins including mannose binding lectin, C1q, pulmonary surfactant 
proteins A and D, C-reactive protein and lipopolysaccharide binding proteins, respectively. 
These molecules facilitate opsonisation for phagocytosis and aid the complement system in 
destroying pathogens that have been bound by these secreted proteins (Medzhitov 2001). The 
third functional group is constituted by signalling receptors such as the Toll-like receptors 
(TLRs), which activate several intracellular signalling cascades, eventually leading to the 
activation of many immune response genes. PAMPs are targets for many PRRs in innate 
immunity. PRRs are expressed on cells positioned strategically in the first line of pathogen 
encounter such as surface epithelia, marginal zone of spleen, and on antigen presenting cells 
(APCs) such as macrophages and dendritic cells. It is important to note that the relatively 
broad spectrum of ligands recognized by TLR family members also includes glycoproteins, 
which points toward the adaptive recognition system (Klein & Nikolaidis 2005). Thus, the TLR 
family possibly represents an important milestone on the way to a recognition system 
characteristic for adaptive immunity (Cooper et al., 2006).  
Recognition of PAMPs can activate direct effector mechanisms of innate immunity such as 
phagocytosis, secretion of antimicrobial peptides and induction of nitric oxide synthase in 
macrophages. Activation of innate immunity results in the secretion of several inflammatory 
cytokines such as interleukin-1, interleukin-6, tumor necrosis factor-┙, type I interferon and 
many chemokines. One of the most important events caused by PAMPs recognition is the 
surface expression of CD80 (B7.1) and CD86 (B7.2) co-stimulatory molecules on APCs, 
which is necessary for the priming of T-dependent adaptive immune responses. Therefore in 
addition to activate direct first line defence mechanisms, innate immunity substantially 
contributes to the adaptive response as well. It is important to note that while PRRs 
recognize molecular patterns instead of specific molecules, and significant redundancy and 
promiscuity exists in the molecular nature of the recognized ligands, PRRs discriminate 
infectious non-self from self perfectly. One plausible explanation for this is that PRRs were 
selected and genetically stabilized over an evolutionary time scale creating an advantage for 
survival, and organisms possessing self reactive PRRs were eventually eliminated. This 
process prevents autoimmunity in those organisms which have only the innate recognition 
system (Cooper et al., 2006; Kvell et al., 2007). 
1.1.2 Antigen specific recognition  
The adaptive immune system containing specialized organs (bone marrow, thymus, spleen, 
lymph nodes, highly structured lymphatic tissues associated with the wet and dry body 
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surfaces), that provide appropriate microenvironment for cells which are committed to 
antigen specific immune defence (T and B cells), appeared later during the evolution. It can 
be generally found in jawed vertebrates, however the earliest species with a variable antigen 
receptor based adaptive-like recognition system are jawless fish (lamprey, hagfish). These 
fish have non-immunoglobulin like clonally distributed receptors with leucine-rich repeats 
(similar to TLRs) generated with a gene rearrangement mechanism other than the 
recombination activating genes (RAG-1:RAG-2) characteristic for jawed vertebrates (Pancer 
et al., 2004). The appearance of adaptive immune system in jawed vertebrates gives the 
impression of a “sudden” change between jawless and jawed fish. This “big bang” 
hypothesis concerning gene duplication events, acquisition of a retrotransposon and the 
appearance of molecules such as major histocompatibilty complex, T- and B-cell receptors 
(Abi Rached et al., 1999) has been challenged by showing that integration of minor changes 
accumulated over an extended evolutionary time lead to the appearance of adaptive 
immune system (Klein & Nikolaidis 2005). Taking into consideration the major 
immunological recognition and activation theories from Janeway’s self/non-self recognition 
to Polly Matzinger’s danger hypothesis and from Burnet’s clonal selection to Smith’s 
quantal theory recently, there is a trend to synthesize the self/non-self vs. danger models, 
particularly proving that receptors distinguish pathogen and danger signals simultaneously 
(Liu et al. 2009). 
In vertebrates the adaptive immunity generates a virtually indefinite pool of recognizing 
molecules: the T and B cell receptors (TCR, BCR), which repertoire makes the adaptation of 
each individual to pathogenic challenges possible. According to the clonal selection 
hypothesis these receptors are clonally distributed, each of them represented by single cell 
clone. The benefit of the high number of available antigen receptors in adaptive immunity 
comes with the cost of potentially dangerous recognition of self-structures, leading to 
autoimmunity. Therefore carefully organized selection mechanisms exist to select the 
potentially useful clones, and to eliminate or inactivate the autoreactive ones. Germline 
genes encoding T and B cell receptors are rearranged by the site specific recombinases RAG-
1, RAG-2. Once these antigen receptors appear on the cell surface, the cell carrying them has 
to survive two types of selection. The first of these is probing the utility of the expressed 
receptor by testing whether it is capable to recognize its ligand in the microenvironment. 
This selection step is termed positive selection, since in the case of the appropriate 
engagement of antigen receptor the cell survives. Although the process was described first 
and in more detail for T cells maturing in the thymus, it was also clearly demonstrated for B 
cell maturing in the bone marrow and spleen (Cancro & Kearney, 2004). The ligand that 
activates the antigen receptor is self-peptide-MHC complex and possibly soluble 
immunoglobulin for T and B cells, respectively. Positive selection operates on a thin margin, 
the strength of the signal generated by antigen receptor engagement must be lower than in 
full activation, thus it provides a partial activation signal. The second selection step 
eliminates clones that possess antigen receptors, which recognize self too strongly, and 
termed negative selection. This mechanism is based on the full activation of antigen receptor 
mediated signalling pathways by self antigens and eventually leads either to the deletion of 
the cell clone, or to long term unresponsiveness of the cell to subsequent stimuli (anergy). 
Alternatively, in the case of B cells, the recombination machinery could be re-activated and 
the other immunoglobulin gene harbouring allele could be rearranged (receptor editing), 
giving the cell a second chance to produce an antigen receptor not reacting with self 
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structures above threshold. Thus, the selection of antigen receptor bearing cells, irrespective 
of whether they belong to the T or B cell pool, is governed by interaction with self ligands 
instead of non-self ligands. The generation of the adaptive immune repertoire is therefore 
strongly self-referential (Janeway 2001). 
2. Natural immunity 
Since the innate recognition system discriminates self from non-self perfectly, the 
contribution of innate immunity to the activation of adaptive responses seems to be of vital 
importance for maintaining tolerance at the periphery. The appearance of co-stimulatory 
molecules on APC surface is critical for the activation of both T and B cells. In the absence of 
appropriate co-stimulation the activation signal remains below threshold level and the 
adaptive immune response will not be activated. The innate and adaptive arms of the 
immune system differ from each other in several important features and their cooperation is 
essential for the correct function of immune defence. As a connection bridging the 
evolutionarily oldest innate and the newly evolved adaptive systems a third compartment 
of immune machineries, the natural immune system has recently been described. A distinct 
set of lymphocytes – both T and B cells – with characteristic phenotypes and specialized 
functions participates in this system. These subsets of cells exhibit common phenotypic 
characteristics and posses both innate and adaptive features, suggesting a transitional stage 
in the immune system’s evolution. The most important cellular components of the natural 
immune system according to recent knowledge are the invariant natural killer T (iNKT) 
cells, mucosa associated invariant T (MAIT) cells, ┛├ T cells and B1 B cells. The functional 
character of antigen recognition by these cells (and the immunoglobulins produced by B1 B 
cells) are closer to the pattern recognition features than to the classical adaptive type 
immunological recognition, however, the recognizing molecules are genuine T and B cell 
surface receptors. 
2.1 Cellular elements of natural immune system 
Among unconventional T cells, only two subsets display both a TCR and selecting MHC 
class Ib molecules highly conserved between species, the iNKT cells and the mucosal 
associated invariant T (MAIT) cells. These two populations express highly restricted TCR 
repertoires consisting of an invariant TCR┙ chain. Both subsets are selected by 
hematopoietic cells expressing evolutionarily conserved non-polymorphic MHC class Ib 
molecules, CD1d for iNKT cells and MHC-related molecule 1 (MR1) for MAIT cells. CD1d-
restricted iNKT cells and MR1-restricted MAIT cells constitute two subsets of 
unconventional T cells that are phylogenetically conserved. Therefore, they are thought to 
play an essential role within the immune system of mammals (Treiner et al., 2005). 
MAIT cells are selected by MR1 in the thymus on a non-B non-T hematopoietic cell, and 
acquire a memory phenotype and expand in the lamina propria of the gastrointestinal tract 
and in mesenterial lymph nodes in a process dependent both upon B cells and the bacterial 
flora. Thus, their development follows a unique pattern at the crossroad of iNKT and ┛├ T 
cells. These features suggest that MAIT cells could be involved in tolerance or immunity to 
infections in the gut. The function of MAIT cells is unknown, but intuitively we can argue 
that it is related to their localization in the gut mucosa. MAIT cells could somehow be 
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involved in the defense against orally acquired pathogens or in non-immune function 
important for gut mucosa homeostasis. MAIT cells might also control the type of the gut 
immune response and/or be involved in oral tolerance. Controlling the balance between 
tolerance and immune response in the gastrointestinal tract is highly important, and could 
explain the striking conservation of the MAIT cells across species. The functional relevance 
of MAIT cells is also underlined by the fact that they represent 1-4% of peripheral T cells in 
human blood (Treiner et al., 2005).  
iNKT cells are selected, expand, and acquire their innate-like phenotype and functions in the 
thymus. They accumulate in the liver and the spleen, independently of the presence of any 
exogenous stimuli such as the normal bacterial flora. INKT cells play an important role in 
both protective and regulatory responses. The nature of the response is determined by the 
initial cytokine environment: interaction with IL-10-producing cells induces regulatory T 
cell type iNKT cells and that with IL-12 producing cells results in Th1 type responses, while 
their production of IFN┛ activates both innate and adaptive immune systems. Upon 
activation of iNKT cells tumor cells can be efficiently eliminated and they also play a role in 
the development of obesity (Lynch et al., 2009).  
The ┛├ TCR repertoire similarly to the repertoire of innate immune receptors could have 
been selected through evolution. Thymic selection does little to constrain ┛├ T cell antigen 
specificities, but instead determines their effector fate. In general, it is believed that ┛├ T 
cells recognize host antigens and play a role in epithelial cell maintenance. Intraepithelial 
lymphocytes (IEL) ontogeny can show minimal dependency upon the thymus, as they can 
escape the thymus at a very early stage and migrate into the gut mucosa where they achieve 
maturation. They may even develop directly from bone marrow derived precursors in 
specific intestinal lymphoid aggregates called cryptopatches. The absence of positive 
selection, and the lack of antigen specific priming, seems ideal for ┛├ T cells to function in 
the first line of defence. When activated through the T cell receptor, antigen-experienced 
cells make IFN┛, whereas antigen-unexperienced ┛├ T cells produce IL-17, a major initiator 
of inflammation. One of the main functions of IL-17 is to promote the expansion and 
maturation of neutrophils in the bone marrow. Therefore the rapid IL-17 response mounted 
by antigen-inexperienced ┛├ T cells would play a critical role at the onset of an acute 
inflammatory response to pathogens that the host encounters for the first time, or to host 
antigens that are only revealed by injury. Furthermore, by acting early in the inflammatory 
response, ┛├ T cells may affect the development of antigen specific ┙┚ T cell and B cell 
responses. Thus ┛├ T cells may play a much larger role in the adaptive immune response 
than previously recognized. Since ┛├ T cells contribute to host immune competence in 
several ways it is understandable why these cells have been maintained throughout 
vertebrate evolution, even when ┙┚ T cells and B cells are also present (Konigshofer & Chien 
2006). 
B1 B cells were originally distinguished from B2 cells on the basis of their expression of CD5, 
a glycoprotein marker previously considered to be T cell specific. CD5 is a type I 
transmembrane glycoprotein with three scavenger receptor cysteine rich domains and a 
highly conserved intracellular domain. Its role in signalling was extensively studied both in 
T and B cells. As it is associated with antigen receptor signalling complexes, the CD5 
molecule considered to be a negative regulator of TCR and BCR signalling. Later on a CD5- 
B1 B cell population was also identified and termed B1b B cells. Differences in the function 
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and developmental requirements of the two B1 B cell subgroups are poorly characterized; 
however, it seems that the BCR/CD19 complex is of crucial importance in developmental 
decisions between B1a and B1b B cells (Haas et al., 2005). 
In addition to surface phenotype, B1 B cells have several unique properties distinguishing 
them from conventional B2 cells. B1 B cells represent a self-renewing population found in 
high number in the peritoneal and pleural cavities, while they are virtually absent from 
peripheral lymph nodes and can be found in low number among splenic B cells. They are 
long lived in vitro, can be forced with phorbol esters to proliferate, and they could not be 
activated through BCR crosslinking. The immunoglobulin repertoire of B1 B cells is 
restricted in the number of immunoglobulin genes used; it is dominated by rearrangement 
of J-proximal V genes and has significantly fever N insertions than the repertoire of B2 cells 
(Kantor et al. 1997). 
There is a long-standing dispute over the developmental origin of B1 B cells in literature 
(Haas et al., 2005). According to the lineage model, B1 B cells are generated from fetal 
precursors present in the fetal liver, omentum and splanchnopleura. This view is 
substantiated by the ability of fetal precursors to reconstitute both the B1 and B2 
compartments in irradiated mice, while adult bone marrow-derived cells reconstitute B2 
cells only. The induced differentiation model of B1 B cell development proposes that the B1 
phenotype is a consequence of T-independent-2 like activation event, thus the specificity of 
BCR is the key factor which determines the B1 phenotype. The differential ability of fetal vs. 
adult precursors to generate B1 B cells is due to the different antigen receptor repertoire of 
these precursors. This argument is supported by several transgenic models in which the 
origin and specificity of the immunoglobulin transgene determined the B1 phenotype 
(Chumley et al., 2000). 
Functions of B1a cells include the participation in the early phases of immune responses and 
most importantly the production of natural antibodies with dominantly IgM isotype, which 
is substantiated by the ability of B1 cells transferred adoptively into irradiated mice to 
restore normal IgM level. These lines of evidence and the properties of B1 B cell produced 
natural antibodies indicate that B1 B cells represent an intermediate stage of evolution 
between innate and adaptive immunity. 
2.2 Natural (auto)antibodies 
Natural antibodies are immunoglobulins mostly of IgM isotype, and are secreted by B1 cells 
without immunization with antigen. These antibodies can recognize genetically conserved 
sequences of pathogens and may serve in the first line of immune defence during an 
infection. In contrast, natural autoantibodies present in the serum of both healthy humans 
and patients with chronic inflammatory or systemic autoimmune diseases recognize a set of 
self-structures that have been conserved during evolution. Most of natural autoantibodies 
belong to the IgM or IgG isotype, and show polyreactivity with a broad range of affinities 
for the recognized epitopes (Lacroix-Desmazes et al., 1998).  
Several functions have been suggested for natural autoantibodies: they may participate in 
the selection of immune repertoires, play a role in the acceleration of primary immune 
responses, and the clearance of apoptotic cells, possess anti-inflammatory effects and 
contribute to the maintenance of immune homeostasis (Lacroix-Desmazes et al., 1998).  
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Discrimination of natural antibodies from natural autoantibodies is somewhat artificial since 
given the limited B1 immunoglobulin gene repertoire driving natural antibody production 
and the numerous distinct antigens recognized it is probable that specificities with self non-
self cross reactivity exist. Based on the above properties of natural antibodies, these 
molecules could be considered as the “innate like arm” of humoral immune system 
(Czömpöly et al., 2008). 
3. Physiologic and pathologic autoantibodies 
The phenomena that natural autoantibodies could recognize self antigens which are also 
targeted by antibodies in autoimmune diseases are not unprecedented. Several lines of 
evidence indicate that antibodies recognizing factor VIII, thyreoglobulin, DNA, endothelial 
cell membrane components etc., are present in sera of both healthy individuals and patients 
with autoimmune diseases. These findings raise the question whether these detected 
antibodies are pathologic autoantibodies or belong to the pool of natural antibodies. It is 
possible that the fine epitope pattern recognized by natural antibodies and disease 
associated autoantibodies within the targeted antigen is different. 
3.1 Characterization of fine epitope structure of the antibodies   
There is a need for epitope mapping on circulating autoantibodies both in the basic and 
clinical immunology and in the immuno-biotechnological research and development. A 
mixture of different natural and pathologic autoantibodies is present in human blood 
samples with various antigen specificity. All the classical physico-chemical and 
immunochemical methods used in antibody characterization are technically difficult in the 
case of autoantigens.  
3.1.1 Methods for determination of epitope specificity  
Several techniques are available for the chemical determination of fine specificity of 
recognition molecules; however, a large scale analysis on serum samples from healthy 
individuals and patients with autoimmune and other diseases is both theoretically and 
technically difficult. Epitope mapping with overlapping synthetic peptides is a useful 
technique, but its constraints include the uncertainties linked to in silico B cell epitope 
prediction used for selection of antigenic regions, the partial coverage of primary sequence 
by synthetic peptides and the possible loss of all unpredicted or conformational epitopes. 
Synthetic overlapping peptides are suitable in the case of well characterized autoantigens. 
Limited proteolysis and the following mass spectroscopic analysis are generally used 
techniques in monoclonal antibody characterizations. Random peptide libraries were 
developed for characterization of epitope specificity on circulating autoantibodies by M13 
filamentous phage system. The method was optimized on monoclonal antibodies and 
applied for serum samples. During our further development lambda phages were used to 
display fragments of previously determined antigens. Bacteriophage surface display of 
peptides is a recently used technique for a variety of applications. This technique resembles 
most the physiological antigen conformation and does not require prior epitope prediction. 
The technology is based on the expression of recombinant peptides or proteins fused to a 
phage coat protein. Its key advantage is in the physical coupling of the displayed protein to 
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the nucleic acid coding for it, making the repeated affinity selection and amplification 
possible. The most commonly used systems are based on fusion to a filamentous phage coat 
protein. However, the life cycle of these phages limits the size of the displayed peptide, 
therefore we have chosen phage lambda for the epitope mapping of naturally occurring and 
pathologic autoantibodies in our different studies. The library contains fragments of the 
antigen with random starting point and length, consequently it overcomes the theoretical 
and technical limitations associated with pre-designed fragments or overlapping synthetic 
peptides (Czömpöly et al., 2008). 
3.1.2 Epitope mapping of naturally occurring antibody family specific for the 
mitochondrial citrate synthase protein antigen 
The basic structural elements of living cells such as the cytoskeleton, metabolic organelles, 
transporters, molecular components of transcription and translation etc., are genetically 
conserved. The maintainence of immunological tolerance against these structures is a basic 
functional duty of immune machinery in all of the three levels. The mitochondrion is 
absolutely necessary for eukaryotic cell function. Genetic alterations which affect 
mitochondrial proteins have serious consequences, if the mutation is compatible with life at 
all. Because of their endosymbiotic evolutionary origin, proteins compartmentalized into 
mitochondria represent an interesting transition from prokaryotic foreign to essential self 
molecules. To date there are only a limited number of epitope mapping analyses performed 
on human antigens that are recognized by natural autoantibodies. In particular, little is 
known about the possible overlap between recognized epitopes of innate and self-reactive 
natural antibodies. The structural and functional conservation of mitochondrial components 
makes them candidate antigens for detailed analysis of evolutionary connections between 
the innate and adaptive immune response. No classical mitochondrion-targeted 
autoimmune disease – with the exception of the primary biliary cirrhosis is known, 
suggesting a well established tolerance both at the innate and adaptive level. The inner 
membrane enzymes, especially the citric acid cycle enzymes offer appropriate models for 
testing their immunoreactivity, because they are in continuous connection with both innate 
and adaptive components of the immune system during physiologic turnover of cells. The 
immunological recognition and the immunoreactivity with these molecules are less studied, 
and the possible changes in physiological autoreactivity under pathologic autoimmune 
conditions remain largely unclear (Czömpöly et al., 2006). To address these issues we have 
chosen a mitochondrial inner membrane enzyme, citrate synthase (CS) as model antigen for 
epitope mapping using sera of healthy individuals and patients having various systemic 
autoimmune disease (systemic lupus erythematosus (SLE), rheumatoid arthritis, 
undifferentiated connective tissue disease, polymyositis/dermatomyosits, systemic sclerosis 
(SSc), Raynaud’s syndrome and Sjögren’s syndrome). The CS enzyme is not only a 
theoretically appropriate model – this is one of the first living protein during the evolution – 
but has also been studied at gene, protein structure and functional levels. 
We demonstrated the presence of antibodies recognizing CS in the sera of both healthy 
individuals and systemic autoimmune patients. The enzyme specific antibodies with IgM 
isotype were more frequently present in all investigated groups than those of IgG or IgA 
isotypes and the incidence of autoantibodies with IgM isotype was significantly higher in 
autoimmune patients compared to the healthy controls. We found that the reactivity against 
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CS of individual sera remained permanently constant over a five year period (Fig.1.), in 
opposite to the anti-CS antibodies with IgG isotype which showed various titer during the 
investigated period on the same individuals. Our findings, that the majority of these 
antibodies have IgM isotype, are already present in infants, and the long term stability of 
their serum titers in adults indicate that these specificities belong to the natural 
autoantibody repertoire established early in postnatal life. The occurrence of anti-CS 
antibodies with IgG isotype we can explain as the physiologic dynamics of normal immune 
defence against different pathogens. 
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Fig. 1. CS reactivity in healthy individuals – 52 blood donors - followed up during a five 
year period with IgM isotype specific indirect ELISA. 
To compare epitopes recognized by natural autoantibodies in healthy individuals with those 
recognized in systemic autoimmune patients we performed the epitope mapping of anti-CS 
antibodies under physiological and pathologic (systemic autoimmune) conditions. Epitope 
mapping with overlapping synthetic peptides is a widely used technique, but its constraints 
include the uncertainties linked to in silico B-cell epitope prediction used for selection of 
antigenic regions, the partial coverage of primary sequence by synthetic peptides and the 
possible loss of all unpredicted or conformational epitopes. Since these effects could have 
influenced our results, we sought to perform the epitope mapping using a basically different 
technique. Bacteriophage surface display of peptides is an extensively used technique for a 
variety of applications. The most commonly used systems are based on fusion to a 
filamentous phage coat protein. However, the life cycle of these phages limits the size of the 
displayed peptide, therefore we have chosen phage lambda for construction of a CS antigen 
-- Base  
-- 3 year 
-- 5 year 
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fragment library to analyze the fine epitope structure of anti-CS autoantibodies (Czömpöly 
et al., 2006). The library contains fragments of CS with random starting point and length; 
consequently it overcomes the theoretical and technical limitations associated with the 
overlapping synthetic peptide approach. With this phage display based approach we 
compared the epitope patterns recognized by anti-CS autoantibodies found in sera of 
healthy individuals and patients with systemic autoimmune diseases. According to our 
results there is no favoured region of the CS molecule recognized exclusively either by 
healthy individuals or patients with systemic autoimmune diseases, but the fine epitope 
pattern is different in the two groups examined (Fig. 2.). 
50 100 150 200 250 300 350 400 450
B
A
 Hum an CS amino acids
 
Fig. 2. Amino acid sequences of CS recognized by healthy individuals (A) and patients with 
systemic autoimmune diseases (B)  
3.1.3 Epitope mapping of pathologic autoantibodies specific for a well conserved 
nuclear antigen, DNA topoisomerase I 
Previously described experiments underlined the necessity for the epitope mapping of an 
autoantibody which is specific for a well defined pathologic condition and has a high 
diagnostic value. Our aim was to decide whether the target antigen of the disease associated 
autoantibody is also recognized by naturally occurring autoantibodies. We assumed that 
comparison of the epitope patterns recognized by natural and disease-associated 
autoantibodies would contribute to the better understanding of the differences between 
natural and pathologic autoantibodies. To address these issues we chose DNA 
topoisomerase I as a model antigen, since anti-topoisomerase I antibodies are important in 
the diagnosis of SSc. 
Using the phage display technique previously developed in our department and optimized 
by analyzing epitopes of anti-CS antibodies, we performed the epitope mapping of anti-
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topoisomerase I autoantibodies and examined whether the target antigen of the disease 
associated autoantibody is also recognized by naturally occurring autoantibodies (Simon et 
al., 2009).  
With the help of the bacteriophage lambda library containing fragments of topoisomerase I 
with random starting point and length we compared the epitope patterns recognized by 
anti-topoisomerase I autoantibodies found in sera of patients with diffuse cutaneous SSc 
(dcSSc), limited cutaneous SSc (lcSSc), and SLE. The results showed that the pattern of 
recognized epitopes is different between dcSSc, lcSSc and SLE patients (Fig. 3.).  
 
Human DNA topoisomerase I amino acids 
Fig. 3. The pattern of recognized topoisomerase I epitopes is different between dcSSc, lcSSc 
and SLE patients 
A common fragment recognized by all patients’ sera was located in the region of amino acid 
sequence (AA) 450-600, which is in agreement with previously published results. In addition 
to this, sera of dcSSc patients recognized several short fragments at the N-terminal part of 
the molecule. Previous studies performed with fusion proteins covering the N-terminal 
domain starting from AA 70 reported that this part of the molecule is recognized by anti-
topoisomerase I antibodies. However, the opposite has also been reported by using a fusion 
protein covering the entire length of the N-terminal domain and showing that this part of 
the molecule is not targeted by anti-topoisomerase I antibodies. These seemingly 
contradictory results may be explained by the different methods and antigen constructs 
used, and most importantly by possible conformational factors, which could influence the 
accessibility of short epitopes buried in the tertiary structure. It is important to note that the 
majority of new epitope containing fragments we identified at the N-terminal part spans 
only 20-30 AA. The 5-25 AA fragment of the N-terminal part of the molecule contains an 
experimentally proven granzyme B cleavage site, thus it is possible that in vivo cleavage of 
topoisomerase I by granzyme B released during T cell mediated cytotoxic responses results 
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in the formation of a neo-antigenic determinant represented by this fragment. In vitro assays 
using the full length antigen or the full length N-terminal domain may fail to detect 
antibodies recognizing these short epitopes suggesting strong conformational sensitivity. 
On the basis of fragments identified by library selection nine maltose binding protein-
topoisomerase I fusion proteins were constructed and expressed (Fig. 4.).  
 
Human DNA topoisomerase I amino acids 
Fig. 4. The constructed and expressed maltose binding protein-topoisomerase I fragment 
fusion proteins 
First we tested recognition of these fusion proteins with sera of healthy individuals and 
found that a significant portion of healthy individuals posses antibodies with IgM and IgG 
isotype against fragment F4. Fragment F4 represent a 150 AA long, genetically conserved 
sequence of topoisomerase I. Using a large number of sera we showed that the presence of 
antibodies against fragment F4 is essentially independent of the age and geographical origin 
of healthy individuals. In addition antibodies against fragment F4 could also be detected in 
sera of patients with inflammatory rheumatic diseases other than SSc and SLE. Anti-F4 
antibodies with IgM isotype are present in the highest titer in sera of anti-topoisomerase I 
antibody positive SSc or SLE patients. It is important to note that all 67 sera from anti-
topoisomerase I antibody positive SSc or SLE patients were found to be positive for anti-F4 
antibodies with IgG isotype, and the titer of these antibodies was the highest in this group 
among all groups tested. The fact that these sera were shown to be negative for anti-
topoisomerase I antibody by a conventional ELISA test using the full length antigen could 
indicate that the sequence represented by fragment F4 could be hidden in the three 
dimensional structure of the full length molecule. These findings raise the possibility that 
antibodies against fragment F4 present in sera of healthy individuals and patients with 
systemic autoimmune diseases could belong to the pool of naturally occurring antibodies. 
To our knowledge these are the first results demonstrating that natural antibodies against 
topoisomerase I are present in human sera. 
It is not unprecedented that natural autoantibodies recognize self antigens which are also 
targeted by antibodies in autoimmune diseases. Since anti-topoisomerase I antibodies can 
also be detected in sera of patients with glomerulonephritis, chronic graft versus host 
dcSSc
SLE
lcSSc
immunodominant 
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disease, primer biliary cirrhosis and in some cases of chronic hepatitis C virus infection 
induced liver diseases the question arises whether these detected antibodies are pathologic 
autoantibodies or belong to the pool of natural antibodies. Fragment F4 represents a 150 
amino acids long sequence of topoisomerase I, consequently it is possible that the fine 
epitope pattern recognized by natural antibodies and disease associated autoantibodies 
within this part of topoisomerase I is different. 
The recognition of the majority of fragments (F2, F3, F5-7, F9) seemed to be characteristic for 
the individual patient sera used for library screening, instead of being characteristic for the 
given disease subgroup. This is in agreement with result of Henry et al., who found both 
individual and longitudinal differences in the recognized topoisomerase I epitopes. 
However, antibodies recognizing the common F4 fragment were detected in all patients’ 
sera tested. In addition to this immunodominant part of topoisomerase I, we identified two 
new regions (F1 and F8) which were previously not shown to be targeted by anti-
topoisomerase I antibodies. Fragment F1 (an evolutionarily relatively new sequence, specific 
for vertebrates) was recognized by 26% of dcSSc patients and antibodies against fragment F8 
(a highly conserved sequence) could be detected in 50% of SLE patients, indicating that 
these fragments could represent characteristic epitopes for dcSSc and SLE, respectively. 
Longitudinal analysis showed that reactivity to fragment F4 was stable, while the reactivity 
to F1 and F8 fragments varied over time. 
3.2 Comparative analysis of fine epitope pattern of natural and pathologic 
autoantibodies  
It is possible that the presence of natural antibodies is essential for the appearance of disease 
associated autoantibodies, since natural autoantibodies can, under appropriate conditions; 
provide the templates for the emergence of higher affinity and class-switched pathogenic 
autoantibodies. IgG isotyped disease associated autoantibodies may recognize genetically 
determined epitopes (epitope patterns) and can be detected in genetically predisposed 
individuals, which was also suggested by a study examining monozygotic twins suffering 
from SLE (Silverman et al., 2008). Thus tolerance against conservative antigens might mostly 
be genetically determined. The permanent impairment of the development and maintenance 
of tolerance can lead to autoimmune disorders. Pattern recognition mechanisms were 
thought to be specific for innate immunity and considered to be the defence mechanisms of 
evolutionarily ancient species. According to our results natural autoantibodies, in terms of 
their antigen recognizing characteristics, resemble the pattern recognition receptors and 
recognize epitope patterns. Pathologic autoantibodies detected in autoimmune diseases 
however are directed mainly against a well defined, disease associated sequence (epitope). 
4. Conclusion  
A large number of circulating antibodies directed against functional structures of the cell 
(nucleic acid, nuclear molecules, receptors, or other functional cell components) can be 
detected in systemic autoimmune diseases. Their presence plays a central role in the 
diagnosis and classification of this kind of disorder. Moreover, several longitudinal cohort 
studies have shown that patients may carry autoantibodies many years before they manifest 
clinical symptoms and detecting these antibodies in serum has been shown to have strong 
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predictive value. Primary structure homologies between the antigens targeted in some 
autoimmune diseases and conserved sequences of different pathogens (viruses and bacteria) 
are well known. Although this so called “molecular mimicry” has been extensively studied, 
direct causality of infections in the development of autoimmune diseases has only been 
verified in a few patients. Apart from the homologies in primary structure, the similarities in 
the physico-chemical molecular shape between the mammalian antigens and the structures 
of microorganisms could provide a real structural basis for the biological recognition 
suggesting a pivotal role of three-dimensional shape of conserved antigens in both targeting 
type immunity and tolerance (Czömpöly et al., 2008). 
According to the orthodox view of phylogenetic development, immunity has reached its 
zenith with the emergence of the adaptive immune system. Consequently, we tend to be 
influenced by anthropocentric views and overlook how other highly developed organisms 
manage living in hostile environments. As recently more data have become available 
regarding non-traditional animal models, it has been suggested that the emergence of 
adaptive immunity is perhaps not the culmination of the evolution of immunity, but simply 
a successful alternative to using innate immunity alone. For millions of years, many species 
could keep-up in the continuous arms-race between pathogen and host called co-evolution 
without the surveillance of adaptive immunity. The complexity of biology should never be 
underestimated as it turns out that those animals lacking RAG-dependent adaptive 
immunity can make up for an equal amount of diversity using highly variable elements of 
innate immunity finally exhibiting adaptive features. On the other hand, in vertebrates, 
adaptive immunity often simply serves as a sophisticated targeting device that recognizes 
and then processes the antigen but finally leaves the messy job of actually clearing up 
pathogens to the immense capacity of innate immunity. Therefore, once again we see that 
borders are blurring and the strict distinction between innate and adaptive immunity might 
need revision (Kvell et al. 2007). Network of natural immunity – including wiled range of 
different cellular elements and naturally occurring antibodies – could explain as the missing 
evolutionary chain between the “classic” innate and adaptive immune system. 
4.1 Clinical relevance of detection of autoantibodies 
Analyzing the recognition of epitopes of natural and pathologic autoantibodies could 
contribute to diagnosis and better understanding of pathomechanisms of systemic 
autoimmune diseases. The onset of the disease may correlate with a switch from production 
of IgM to IgG isotyped antibodies. Nevertheless, the exact role of autoreactive IgM in the 
autoantibody response and the switch to other isotypes is not known. It has to be mentioned 
that IgM isotyped natural autoantibodies can have a role in protection from autoimmunity 
by facilitating the removal of apoptotic cells and increasing the tolerance of B cells to self 
antigen. Since one of the essential functions of the immune system is the prevention of self 
antigens to stimulate an inflammatory reaction, the presence of autoantibodies is the 
consequence of a breakdown or failure of B cell tolerance toward the corresponding 
autoantigens. The timing of exposure, the level of affinity of the autoreactive IgM 
autoantibodies and their local concentration may determine which scenario applies, i.e., 
autoimmunity or tolerance. Detection of autoantibodies reacting with self antigens is 
generally used in laboratory diagnostics. However, their presence in serum samples doesn’t 
mean automatically a pathologic condition. Natural autoantibodies could recognize self 
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antigens which are also targeted by antibodies in autoimmune diseases. The immune 
response could be explained by a general recognition of the immunodominant part of the 
molecule, followed by appearance of antibodies directed against disease associated 
sequences (Czömpöly et al., 2009). Detection of autoantibodies recognizing different 
epitopes of these antigens could be a useful tool in laboratory diagnostics (Simon et al., 
2009). 
4.1.1 Diagnostic issues of natural and pathologic autoantibodies  
Early diagnosis and initiation of adequate therapy as soon as possible is crucial in systemic 
autoimmune diseases such as SSc and SLE, because after insidious onset of the disease the 
development of internal organ manifestations can lead to death of the patient in a few years. 
Anti-topoisomerase I autoantibodies are considered to be associated with dcSSc. However, 
the presence of anti-topoisomerase I autoantibodies is not entirely restricted to this subset, 
since anti-topoisomerase I antibodies have been demonstrated in lcSSc, SLE and other 
inflammatory diseases. The fact that anti-F4 antibodies were detected in sera which were 
tested negative for anti-topoisomerase I antibody by a conventional ELISA kit using the full 
length antigen indicates that an ELISA test using recombinant F4 fragment might be a more 
sensitive way to determine anti-topoisomerase I positivity and could contribute to early 
diagnosis and monitoring the activity of SSc (Simon et al., 2009). 
4.1.2 Prognostic value of epitope pattern  
In systemic autoimmune diseases the prognosis is mostly determined by the activity of the 
disease and the extent of the developed irreversible lesions. Since anti-topoisomerase I 
autoantibody is found to be associated with increased mortality, pulmonary fibrosis, 
musculoskeletal and cardiac involvement, proteinuria and the level of anti-topoisomerase I 
autoantibody correlates with the extent of fibrosis of the skin and internal organ 
involvement in dcSSc, it may serve as an activity marker of disease (Minier et al., 2010). 
Statistical analysis of clinical data (extent of skin involvement, hand contractures, azotemia 
and/or malignant hypertension, cardiac involvement, pulmonary artery hypertension, 
dysmotility and stricture/dilatation of esophagus, extent of lung fibrosis, forced vital 
capacity) failed to demonstrate associations between anti-topoisomerase I antibody epitope 
specificity and clinical presentation of the disease. This is in agreement with results also 
reporting lack of clear association between changes in the anti–topoisomerase I antibody 
response and clinical parameters (Henry et al., 2005). However, there was a significant 
difference between F1 negative and F1 positive groups of dcSSc patients in average age and 
the duration of the disease. The difference in the duration of disease between anti-F1 
antibody positive and negative dcSSc patients, together with findings of our longitudinal 
analysis, may indicate that the anti-topoisomerase I immune response could be explained by 
a general recognition of the immunodominant part on the molecule (fragment F4), and the 
disease associated autoantibodies may target the N-terminal part later during the course of 
the disease. Thus autoantibodies against fragment F1 may represent a new marker of late 
stage dcSSc (Simon et al., 2009). 
Comparison of clinical data of anti-F8 positive and anti-F8 negative SLE patients suggested 
that SLE patients with antibody against fragment F8 have Raynaud’s phenomenon and a 
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milder presentation of the disease (lack of arthritis, central nervous system and kidney 
involvement). 
Discrimination between naturally occurring and pathologic autoantibodies is available 
according to their recognition patterns, and this is not only a theoretical question but holds 
important practical – diagnostic and prognostic – consequences in the daily laboratory 
routine.  
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